The latest developments across the GLP-1 landscape, from new drug approvals and clinical research to pricing changes and policy shifts. Stay informed on the updates that affect Ozempic, Wegovy, Mounjaro, and the wider category.
News & Updates
GLP-1 medications like semaglutide and tirzepatide are among the most effective weight loss treatments available, but their high costs create real access barriers for many Americans, especially people of color. This article breaks down why the affordability gap exists, who it affects most, and what practical steps you can take to reduce your own costs right now.
Novo Nordisk, the maker of Ozempic and Wegovy, is calling for government-targeted subsidies for weight-loss medications. This could reshape who gets access and at what cost. Here is what patients need to understand about where this debate is heading and how to manage costs in the meantime.
Novo Nordisk's stock and Wegovy sales momentum has shown signs of cooling after a period of strong growth. For patients currently on Wegovy or considering it, this shift has real implications for pricing, availability, and competition in the GLP-1 market. Here's what you need to know.
CoreAge Rx is an online GLP-1 platform offering semaglutide and tirzepatide prescriptions without in-person visits. This review breaks down how it works, what it costs, and whether it's a smart choice compared to other telehealth providers in 2026.
Oral semaglutide for weight loss has crossed 5 million prescriptions, pushing Novo Nordisk to raise its 2026 financial outlook. For patients considering GLP-1 therapy, this milestone raises practical questions about access, cost, and how the pill compares to the injectable version of Wegovy.
Bank of America's CEO revealed the company spends $250 million annually on GLP-1 medications for its workforce. This signals a major shift in how employers view weight loss drugs, and it has real implications for patients navigating coverage and costs.
Novo Nordisk is rolling out an oral version of Wegovy (semaglutide) in its first European Union country, a significant step for weight loss treatment. This article breaks down what the pill is, how it compares to the injectable, and what it could mean for US patients watching closely.
Amazon Pharmacy has launched a dedicated GLP-1 delivery service, giving patients a new way to access weight loss medications like semaglutide and tirzepatide. This guide breaks down what the service offers, how pricing compares, and what to consider before switching from your current pharmacy. Understanding your options has never been more important.
